Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 28, 2014; 20(24): 7819-7829
Published online Jun 28, 2014. doi: 10.3748/wjg.v20.i24.7819
Published online Jun 28, 2014. doi: 10.3748/wjg.v20.i24.7819
Figure 1 Multiple randomized phase III trials have been completed in the last decades; however, we have not been able to cross the barrier of 12 mo survival in advanced pancreatic cancer.
- Citation: Lamarca A, Feliu J. Pancreatic biomarkers: Could they be the answer? World J Gastroenterol 2014; 20(24): 7819-7829
- URL: https://www.wjgnet.com/1007-9327/full/v20/i24/7819.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i24.7819